Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with diabetes mellitus
Authors:
Open Access
- 1 June 2014
- Vol. 26 (3) , 341-344
Abstract
The side effects of tamoxifen are generally mild, including the effect on lipoprotein metabolism. However, there are few cases of severe tamoxifen induced hypertriglyceridemia. Hypertriglyceridemia is a marked risk factor for acute pancreatitis and approximately 2% to 5% of cases of acute pancreatitis are related to drugs. We report on tamoxifen-induced hypertriglyceridemia and acute pancreatitis in a 40 years old woman with type 2 diabetes mellitus occurred by dexamethasone. She was treated with insulin infusion and fenofibrate, and goserelin acetate was started instead of tamoxifen after discharge from the hospital. Also, probable pathogenic hypotheses about the correlation between tamoxifen and dexamethasone induced type 2 diabetes mellitus on severe acute pancreatitis are provided. Clinicians should take care of risks of severe acute pancreatitis on using tamoxifen, especially for patients with dexamethasone induced diabetes mellitus. These individuals should undergo pre-post tamoxifen lipid screening and careful history taking of drugs, including dexamethasone.Keywords
This publication has 14 references indexed in Scilit:
- Protein Phosphatase 5 Mediates Lipid Metabolism through Reciprocal Control of Glucocorticoid Receptor and Peroxisome Proliferator-activated Receptor-γ (PPARγ)Journal of Biological Chemistry, 2011
- Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with positive rechallenge.2010
- Incidence, Severity, and Etiology of Drug-Induced Acute PancreatitisDigestive Diseases and Sciences, 2010
- The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-AnalysisAmerican Journal of Epidemiology, 2010
- Severe hypertriglyceridemia and pancreatitis: presentation and managementCurrent Opinion in Lipidology, 2009
- Side Effects of Adjuvant Treatment of Breast CancerNew England Journal of Medicine, 2001
- Severe hypertriglyceridaemia and hypercholesterolaemia associated with tamoxifen useClinical Oncology, 1998
- Effects of Tamoxifen Treatment on Plasma Lipids and Lipoprotein Lipid CompositionThe Journal of Clinical Endocrinology & Metabolism, 1990
- Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifenBritish Journal of Surgery, 1987
- Glucocorticoids and triglyceride transport: Effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the ratMetabolism, 1976